Globus Medical, Inc.GMEDNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank79
5Y CAGR+9.8%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+9.8%/yr
Long-term compound
Percentile
P79
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 27.16% |
| Q3 2025 | 77.39% |
| Q2 2025 | -21.54% |
| Q1 2025 | 60.94% |
| Q4 2024 | 25.31% |
| Q3 2024 | -3.07% |
| Q2 2024 | 520.51% |
| Q1 2024 | -21.00% |
| Q4 2023 | 2405.69% |
| Q3 2023 | -99.39% |
| Q2 2023 | 17.39% |
| Q1 2023 | 4.40% |
| Q4 2022 | -9.50% |
| Q3 2022 | -11.91% |
| Q2 2022 | 45.93% |
| Q1 2022 | 155.19% |
| Q4 2021 | -65.87% |
| Q3 2021 | 16.25% |
| Q2 2021 | -15.90% |
| Q1 2021 | -6.81% |
| Q4 2020 | 17.04% |
| Q3 2020 | 295.65% |
| Q2 2020 | -189.86% |
| Q1 2020 | -43.08% |
| Q4 2019 | 18.83% |
| Q3 2019 | -1.88% |
| Q2 2019 | 15.62% |
| Q1 2019 | -14.27% |
| Q4 2018 | 12.92% |
| Q3 2018 | -9.11% |
| Q2 2018 | -7.66% |
| Q1 2018 | -5.64% |
| Q4 2017 | 35.10% |
| Q3 2017 | -4.22% |
| Q2 2017 | -7.30% |
| Q1 2017 | 12.85% |
| Q4 2016 | -5.12% |
| Q3 2016 | -0.71% |
| Q2 2016 | -11.51% |
| Q1 2016 | -23.48% |